What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control and Prevention stand up to her boss? And can Amgen overcome its obesity drug’s side effects?
We discuss all that and more on this on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
